The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000. ,
DOI : 10.1016/S0092-8674(00)81683-9
Inflammation and cancer, Nature, vol.2, issue.6917, pp.860-867, 2002. ,
DOI : 10.1006/cyto.1996.0074
Smoldering and polarized inflammation in the initiation and promotion of malignant disease, Cancer Cell, vol.7, issue.3, pp.211-217, 2005. ,
DOI : 10.1016/j.ccr.2005.02.013
NF-??B: linking inflammation and immunity to cancer development and progression, Nature Reviews Immunology, vol.100, issue.10, pp.749-759, 2005. ,
DOI : 10.1038/nri1703
A cytokine-mediated link between innate immunity, inflammation, and cancer, Journal of Clinical Investigation, vol.117, issue.5, pp.1175-1183, 2007. ,
DOI : 10.1172/JCI31537
Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators, Seminars in Cancer Biology, vol.16, issue.1, pp.38-52, 2006. ,
DOI : 10.1016/j.semcancer.2005.07.006
Cytokines in cancer immunity and immunotherapy, Immunological Reviews, vol.63, issue.1, pp.275-293, 2004. ,
DOI : 10.1182/blood.V99.4.1259
Tumor-Driven Evolution of Immunosuppressive Networks during Malignant Progression, Cancer Research, vol.66, issue.11, pp.5527-5536, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-4128
Immunodeficiency and cancer: prospects for correction, International Immunopharmacology, vol.3, issue.8, pp.1061-1071, 2003. ,
DOI : 10.1016/S1567-5769(03)00060-2
NF-??B functions as a tumour promoter in inflammation-associated cancer, Nature, vol.2, issue.7007, pp.461-466, 2004. ,
DOI : 10.1006/scbi.2000.0360
Inflammation and cancer: the long reach of Ras, Nature Medicine, vol.267, issue.1, pp.20-21, 2005. ,
DOI : 10.1016/j.cell.2004.07.013
The molecular architecture of the TNF superfamily, Trends in Biochemical Sciences, vol.27, issue.1, pp.19-26, 2002. ,
DOI : 10.1016/S0968-0004(01)01995-8
APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth, The Journal of Experimental Medicine, vol.188, issue.6, pp.1185-1190, 1998. ,
DOI : 10.1146/annurev.med.45.1.491
APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death, Cancer Res, vol.60, pp.1021-1027, 2000. ,
TALL-1 is a novel member of the TNF family that is down-regulated by mitogens, J Leukoc Biol, vol.65, pp.680-683, 1999. ,
TACI and BCMA are receptors for a TNF homologue implicated in Bcell autoimmune disease, Nature, vol.404, issue.6781, pp.995-999, 2000. ,
DOI : 10.1038/35010115
BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth, The Journal of Experimental Medicine, vol.85, issue.11, pp.1747-1756, 1999. ,
DOI : 10.1126/science.7537388
BLyS: Member of the Tumor Necrosis Factor Family and B Lymphocyte Stimulator, Science, vol.285, issue.5425, pp.260-263, 1999. ,
DOI : 10.1126/science.285.5425.260
BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes, International Immunology, vol.7, issue.7, pp.1093-1106, 1995. ,
DOI : 10.1093/intimm/7.7.1093
An APRIL to remember: novel TNF ligands as therapeutic targets, Nature Reviews Drug Discovery, vol.114, issue.3, pp.235-246, 2006. ,
DOI : 10.1074/jbc.M305754200
TNF Receptor Family Member BCMA (B Cell Maturation) Associates with TNF Receptor-Associated Factor (TRAF) 1, TRAF2, and TRAF3 and Activates NF-??B, Elk-1, c-Jun N-Terminal Kinase, and p38 Mitogen-Activated Protein Kinase, The Journal of Immunology, vol.165, issue.3, pp.1322-1330, 2000. ,
DOI : 10.4049/jimmunol.165.3.1322
The TNF family members BAFF and APRIL: the growing complexity, Cytokine & Growth Factor Reviews, vol.14, issue.3-4, pp.311-324, 2003. ,
DOI : 10.1016/S1359-6101(03)00023-6
The BAFF/APRIL system: life beyond B lymphocytes, Molecular Immunology, vol.42, issue.7, pp.763-772, 2005. ,
DOI : 10.1016/j.molimm.2004.06.041
Airway Epithelial Cells Produce B Cell-Activating Factor of TNF Family by an IFN-??-Dependent Mechanism, The Journal of Immunology, vol.177, issue.10, pp.7164-7172, 2006. ,
DOI : 10.4049/jimmunol.177.10.7164
cDNA cloning, expression and bioactivity of porcine BAFF, Developmental & Comparative Immunology, vol.31, issue.12, pp.1211-1219, 2007. ,
DOI : 10.1016/j.dci.2007.03.006
Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor, Oncogene, vol.23, issue.17, pp.3005-3012, 2004. ,
DOI : 10.1038/sj.onc.1207350
April and Baff Connect Autoimmunity and Cancer: Figure 1, The Journal of Experimental Medicine, vol.60, issue.11, pp.35-38, 2000. ,
DOI : 10.1084/jem.192.10.1453
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies, Arch Pathol Lab Med, vol.109, pp.716-721, 1985. ,
Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase, EMBO reports, vol.1, issue.8, pp.945-951, 2001. ,
DOI : 10.1093/embo-reports/kve198
Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis, Trends in Cell Biology, vol.9, issue.1, pp.28-35, 1999. ,
DOI : 10.1016/S0962-8924(98)01382-8
TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis, Journal of Biological Chemistry, vol.272, issue.51, pp.32401-32410, 1997. ,
DOI : 10.1074/jbc.272.51.32401
Synthesis and release of B-lymphocyte stimulator from myeloid cells, Blood, vol.97, issue.1, pp.198-204, 2001. ,
DOI : 10.1182/blood.V97.1.198
Involvement of Tweak in Interferon ?????Stimulated Monocyte Cytotoxicity, The Journal of Experimental Medicine, vol.865, issue.9, pp.1373-1380, 2000. ,
DOI : 10.1016/S0923-2494(99)80036-4
BAFF, APRIL and their receptors: Structure, function and signaling, Seminars in Immunology, vol.18, issue.5, pp.263-275, 2006. ,
DOI : 10.1016/j.smim.2006.04.006
The signaling adaptors and pathways activated by TNF superfamily, Cytokine & Growth Factor Reviews, vol.14, issue.3-4, pp.193-209, 2003. ,
DOI : 10.1016/S1359-6101(03)00021-2
Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation, Cell Death and Differentiation, vol.26, issue.6, pp.637-648, 2005. ,
DOI : 10.1038/sj.cdd.4401647
Molecular diversity of heparan sulfate, Journal of Clinical Investigation, vol.108, issue.2, pp.169-173, 2001. ,
DOI : 10.1172/JCI200113530
Heparan sulfate: growth control with a restricted sequence menu, Journal of Clinical Investigation, vol.108, issue.3, pp.357-361, 2001. ,
DOI : 10.1172/JCI13713
Specificities of heparan sulphate proteoglycans in developmental processes, Nature, vol.404, issue.6779, pp.725-728, 2000. ,
DOI : 10.1038/35008000
Identification of proteoglycans as the APRIL-specific binding partners, The Journal of Experimental Medicine, vol.103, issue.9, pp.1375-1383, 2005. ,
DOI : 10.1002/eji.1830221136
TACI regulates IgA production by APRIL in collaboration with HSPG, Blood, vol.109, pp.2961-2967, 2007. ,
DOI : 10.1182/blood-2006-08-041772
Selective activation of TACI by syndecan-2, Blood, vol.107, issue.8, pp.3235-3242, 2006. ,
DOI : 10.1182/blood-2005-01-0256
The source of APRIL up-regulation in human solid tumor lesions, Journal of Leukocyte Biology, vol.80, issue.4, pp.697-704, 2006. ,
DOI : 10.1189/jlb.1105655
Functions of Cell Surface Heparan Sulfate Proteoglycans, Annual Review of Biochemistry, vol.68, issue.1, pp.729-777, 1999. ,
DOI : 10.1146/annurev.biochem.68.1.729
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL, Blood, vol.109, issue.2, pp.729-739, 2007. ,
DOI : 10.1182/blood-2006-04-015958
Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs, Trends in Immunology, vol.28, issue.9, 2007. ,
DOI : 10.1016/j.it.2007.07.003
Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/ TCF4(TCF7L2)-dependent pathway, Cell Death Differ, 2007. ,
Novel Treatments for Obesity and Osteoporosis: Targeting Apoptotic Pathways in Adipocytes, Current Medicinal Chemistry, vol.12, issue.19, pp.2215-2225, 2005. ,
DOI : 10.2174/0929867054864886